Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Atlanta
        • Atlanta Leadership
        • Atlanta Contacts
      • Caribbean
        • Caribbean Leadership
        • Caribbean Contacts
      • Chicago
        • Chicago Leadership
        • Chicago Contacts
      • Dallas
        • Dallas Leadership
        • Dallas Contacts
      • Detroit
        • Detroit Leadership
        • Detroit Contacts
      • El Paso
        • El Paso Leadership
        • El Paso Contacts
      • Headquarters
      • Houston
        • Houston Leadership
        • Houston Contacts
      • Los Angeles
        • Los Angeles Leadership
        • Los Angeles Contacts
      • Louisville
        • Louisville Leadership
        • Louisville Contacts
      • Miami
        • Miami Leadership
        • Miami Contacts
      • New England
        • New England Leadership
        • New England Contacts
      • New Jersey
        • New Jersey Contacts
      • New Orleans
        • New Orleans Leadership
        • New Orleans Contacts
      • New York
        • New York Leadership
        • New York Contacts
      • Omaha
        • Omaha Leadership
        • Omaha Contacts
      • Philadelphia
        • Philadelphia Leadership
        • Philadelphia Contacts
      • Phoenix
        • Phoenix Leadership
        • Phoenix Contacts
      • Rocky Mountain
        • Rocky Mountain Contacts
      • San Diego
        • San Diego Leadership
        • San Diego Contacts
      • San Francisco
        • San Francisco Contacts
      • Seattle
        • Seattle Contacts
      • St. Louis
        • St. Louis Leadership
        • St. Louis Contacts
      • Washington, DC
        • Washington Leadership
        • Washington Contacts
    • DEA Museum
    • Foreign Offices
      • Africa
      • Andean
      • Caribbean
      • Europe
      • Far East
      • Middle East
      • North and Central America
      • Southern Cone
    • Operational Divisions
      • Aviation Division
      • Diversion Control Division
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
        • Leadership
        • Mission
        • Services
        • Contacts
      • Forensic Sciences
        • Computer Forensics Program
        • Environmental Management
        • Laboratories
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
        • State and Local Task Forces
    • Education and Prevention
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Red Ribbon
        • Kiki and the History of Red Ribbon Week
        • Red Ribbon Toolkit - Resources For Your Community
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
      • Special Agent Job Announcements
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • How to Apply
      • Employment Requirements
      • Equal Opportunity Employer
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
  • Resources
    • Recovery Resources
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources

United States Drug Enforcement Administration

  • Search
  • Full Menu

Main Menu

  • Who We Are
  • What We Do
  • Careers
  • Resources
  • Submit A Tip
  • Get Updates
  • Scam Alert
  • English
  • ES

PUBLIC SAFETY ALERT

DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine - DEA Reports Widespread Threat of Fentanyl Mixed with Xylazine

Drug Enforcement Administration

Orville O. Greene Special Agent in Charge
Detroit
@DEADetroitDiv
November 08, 2017
Contact: Brian McNeal
Phone Number: (571) 362-1498
For Immediate Release

Michigan Physician Sentenced To Federal Prison For Writing Fraudulent Prescriptions To Obtain Controlled Substances

KALAMAZOO, Mich. - Acting U.S. Attorney Andrew Birge announced that on Monday, November 6, 2017, Mark Edward Brewster, M.D., of Traverse City, Michigan, was sentenced to 10 months in federal prison.  The sentence followed Brewster’s pleading guilty to writing fraudulent prescriptions to obtain controlled substances. Brewster will also pay restitution to Blue Cross Blue Shield of Michigan, which paid for a number of Brewster’s fraudulent prescriptions. Brewster further surrendered his DEA registration to federal authorities as part of this investigation.

A federal investigation revealed that between 2006 and 2015, Brewster wrote over 150 fraudulent prescriptions in the names of seven different people in order to obtain quantities of Ritalin, a Schedule II controlled substance that ultimately exceeded five times the maximum FDA-approved adult dosage. Brewster started issuing fraudulent prescriptions before he graduated from medical school, wrote fraudulent prescriptions while he was on state court probation for a domestic violence conviction, and continued writing fraudulent prescriptions after being fired by a northern Michigan hospital for his prescribing practices.

When Brewster’s prescriptions to his girlfriend became the subject of a state licensing investigation in 2015, he assured state investigators that, going forward, there was "zero chance" he would write prescriptions for anyone other than his patients. Brewster continued writing fraudulent prescriptions the very next day and concealed those prescriptions by writing them in the names of his girlfriend’s minor children and others who were unknown to licensing investigators.

During his nearly decade-long prescription fraud, Brewster boasted, in text messages, that he was "[s]ticking it to the man" by having some of his fraudulent prescriptions paid for by other people’s private insurance. Brewster also falsified progress notes in a patient’s medical record to cover other fraudulent prescriptions. When he became aware of the federal investigation, Brewster instructed people not to tell the DEA anything about his fraudulent prescriptions.

At sentencing, U.S. District Judge Paul Maloney described Brewster’s crime as "a product of the doctor’s arrogance" and noted that Brewster caused a number of otherwise law-abiding people to become involved in felonious conduct. The sentence, Judge Maloney said, should deter other health care professionals who might consider illegally abusing their prescribing authorities to obtain drugs for themselves or others.

In connection with this investigation, Brewster’s girlfriend, Nicole Aiello, R.N., also pleaded guilty to aiding and abetting Brewster in illegally obtaining controlled substances. Aiello will be sentenced on January 5, 2018. To date, the U.S. Attorney’s Office has further recovered $46,200.00 in civil penalties from other individuals who filled fraudulent prescriptions and returned controlled substances to Brewster.

"The U.S. Attorney’s Office will aggressively use all available criminal, civil, and administrative remedies when health care professionals abuse their licenses to illegally prescribe controlled substances for themselves or others," Acting U.S. Attorney Birge said. "The national epidemic of prescription drug abuse warrants the serious attention that we give this conduct."

This case was investigated by the U.S. Drug Enforcement (DEA), Blue Cross Blue Shield of Michigan, and the U.S. Attorney’s Office. The case was prosecuted by Assistant U.S. Attorneys Adam B. Townshend and Raymond E. Beckering III.

  • Facebook
  • Twitter
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Drug Prevention
    • Law Enforcement
    • Diversion Control Division
    • News
  • Careers
    • Overview
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
  • Resources
    • Drug Information
    • Employee Assistance Program
    • Equal Opportunity Employer
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
  • Policies
    • Accessibility, Plug-ins & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
Home

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook Twitter LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster